Entrada Therapeutics, Inc.

TRDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001689375

Price chart

Open-market purchases and sales by TRDA insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 9, 20267:24 PM ETSep 4 – Sep 9, 2026MPM BIOVENTURES 2018, L.P. and 2 others10% OwnerSSaleCommon Stock−259.84K$7.3345−$1.91M3.89M−6.3%SEC
Sep 9, 20267:23 PM ETSep 4 – Sep 9, 2026GADICKE ANSBERT and 9 others10% OwnerSSaleCommon Stock−259.84K$7.3345−$1.91M3.89M−6.3%SEC
Sep 3, 20267:21 PM ETSep 1 – Sep 3, 2026MPM BIOVENTURES 2018, L.P. and 2 others10% OwnerSSaleCommon Stock−86.48K$7.1388−$617.38K4.14M−2.0%SEC
Sep 3, 20267:21 PM ETSep 1 – Sep 3, 2026GADICKE ANSBERT and 9 others10% OwnerSSaleCommon Stock−86.48K$7.1388−$617.38K4.14M−2.0%SEC
Aug 31, 20266:26 PM ETAug 27 – Aug 31, 2026MPM BIOVENTURES 2018, L.P. and 2 others10% OwnerSSaleCommon Stock−86.91K$7.0849−$615.78K4.23M−2.0%SEC

The largest institutional positions in TRDA at the end of Q2 2026.

Institutions holding TRDA in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BAKER BROS. ADVISORS LP5,072,730$37.34M0.19%00.0%Unchanged
5AM Venture Management, LLC4,056,379$29.85M10.37%00.0%Unchanged
BlackRock, Inc.2,583,333$19.01M0.00%+224,540+9.5%Added
Merck & Co., Inc.1,739,768$12.8M2.43%+1,739,768New
VANGUARD CAPITAL MANAGEMENT LLC1,269,634$9.34M0.00%+13,621+1.1%Added